Boston Scientific Corp. increased total compensation for chief executive officer Michael F. Mahoney t10.1 percent to $11.6 million last year, according to a regulatory filing Tuesday by the Marlborough-based medical device maker.
The proxy statement, posted in advance of the company’s May 3 annual shareholders meeting said Mahoney...
